IRBETAN irbesartan 75mg film-coated tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

irbesartan, Quantity: 75 mg

MAH:

Medis Pharma Pty Ltd

INN:

Irbesartan

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: lactose monohydrate; croscarmellose sodium; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 4000

administration_route:

Oral

units_in_package:

30s

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Irbesartan is indicated for the following: For the treatment of hypertension. For delaying the progression of renal disease in hypertensive type II diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

leaflet_short:

Visual Identification: White to off-white, oval shaped, biconvex, film coated tablet, debossed with "L172" on one side and "75" on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

authorization_status:

Licence status A

authorization_date:

2012-11-13